Thermo Fisher Scientific Comprehensive Income 2010-2024 | TMO
Thermo Fisher Scientific comprehensive income from 2010 to 2024. Comprehensive income can be defined as the change in net assets of a business enterprise during a period from transactions and other events and circumstances from nonowner sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.
- Thermo Fisher Scientific comprehensive income for the quarter ending September 30, 2024 was $-2.477B, a 18.17% decline year-over-year.
- Thermo Fisher Scientific comprehensive income for 2023 was $-3.224B, a 4.03% increase from 2022.
- Thermo Fisher Scientific comprehensive income for 2022 was $-3.099B, a 33.06% increase from 2021.
- Thermo Fisher Scientific comprehensive income for 2021 was $-2.329B, a 17.03% decline from 2020.
| Thermo Fisher Scientific Annual Comprehensive Income (Millions of US $) |
|
|---|---|
| 2023 | $-3,224 |
| 2022 | $-3,099 |
| 2021 | $-2,329 |
| 2020 | $-2,807 |
| 2019 | $-2,679 |
| 2018 | $-2,498 |
| 2017 | $-2,003 |
| 2016 | $-2,636 |
| 2015 | $-1,997 |
| 2014 | $-1,285 |
| 2013 | $-77 |
| 2012 | $-150 |
| 2011 | $-400 |
| 2010 | $44 |
| 2009 | $92 |
| Thermo Fisher Scientific Quarterly Comprehensive Income (Millions of US $) |
|
|---|---|
| 2024-09-30 | $-2,477 |
| 2024-06-30 | $-2,413 |
| 2024-03-31 | $-2,764 |
| 2023-12-31 | $-3,224 |
| 2023-09-30 | $-3,027 |
| 2023-06-30 | $-2,924 |
| 2023-03-31 | $-3,054 |
| 2022-12-31 | $-3,099 |
| 2022-09-30 | $-2,928 |
| 2022-06-30 | $-2,724 |
| 2022-03-31 | $-2,343 |
| 2021-12-31 | $-2,329 |
| 2021-09-30 | $-2,654 |
| 2021-06-30 | $-2,630 |
| 2021-03-31 | $-2,562 |
| 2020-12-31 | $-2,807 |
| 2020-09-30 | $-2,970 |
| 2020-06-30 | $-2,989 |
| 2020-03-31 | $-3,088 |
| 2019-12-31 | $-2,679 |
| 2019-09-30 | $-2,722 |
| 2019-06-30 | $-2,630 |
| 2019-03-31 | $-2,509 |
| 2018-12-31 | $-2,498 |
| 2018-09-30 | $-2,519 |
| 2018-06-30 | $-2,491 |
| 2018-03-31 | $-2,042 |
| 2017-12-31 | $-2,003 |
| 2017-09-30 | $-2,183 |
| 2017-06-30 | $-2,256 |
| 2017-03-31 | $-2,474 |
| 2016-12-31 | $-2,636 |
| 2016-09-30 | $-2,155 |
| 2016-06-30 | $-2,082 |
| 2016-03-31 | $-1,867 |
| 2015-12-31 | $-1,997 |
| 2015-09-30 | $-1,886 |
| 2015-06-30 | $-1,595 |
| 2015-03-31 | $-1,847 |
| 2014-12-31 | $-1,285 |
| 2014-09-30 | $-724 |
| 2014-06-30 | $-112 |
| 2014-03-31 | $-63 |
| 2013-12-31 | $-77 |
| 2013-09-30 | $-150 |
| 2013-06-30 | $-456 |
| 2013-03-31 | $-329 |
| 2012-12-31 | $-150 |
| 2012-09-30 | $-200 |
| 2012-06-30 | $-458 |
| 2012-03-31 | $-151 |
| 2011-12-31 | $-400 |
| 2011-09-30 | $-279 |
| 2011-06-30 | $266 |
| 2011-03-31 | $164 |
| 2010-12-31 | $44 |
| 2010-09-30 | $79 |
| 2010-06-30 | $-150 |
| 2010-03-31 | $-47 |
| 2009-12-31 | $92 |
| 2009-09-30 | $79 |
| 2009-06-30 | $4 |
| 2009-03-31 | $-258 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $217.348B | $42.857B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $203.988B | 93.58 |
| Alcon (ALC) | Switzerland | $45.073B | 30.16 |
| Edwards Lifesciences (EW) | United States | $41.952B | 26.64 |
| IQVIA Holdings (IQV) | United States | $35.950B | 19.81 |
| IDEXX Laboratories (IDXX) | United States | $34.289B | 40.38 |
| DexCom (DXCM) | United States | $33.759B | 50.84 |
| Waters (WAT) | United States | $23.998B | 35.49 |
| STERIS (STE) | Ireland | $21.743B | 25.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.798B | 0.00 |
| Hologic (HOLX) | United States | $16.119B | 17.50 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.577B | 14.96 |
| Globus Medical (GMED) | United States | $12.635B | 32.00 |
| Sysmex ADR (SSMXY) | Japan | $12.243B | 38.39 |
| Penumbra (PEN) | United States | $10.352B | 101.40 |
| Masimo (MASI) | United States | $9.509B | 46.01 |
| Glaukos (GKOS) | United States | $8.767B | 0.00 |
| Teleflex (TFX) | United States | $8.387B | 13.38 |
| Integer Holdings (ITGR) | United States | $4.804B | 27.23 |
| Inari Medical (NARI) | United States | $4.666B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $3.807B | 0.00 |
| Veracyte (VCYT) | United States | $3.444B | 103.35 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 15.90 |
| Nihon Kohden (NHNKY) | Japan | $2.554B | 19.40 |
| Tandem Diabetes Care (TNDM) | United States | $2.388B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.309B | 20.76 |
| TransMedics (TMDX) | United States | $2.199B | 69.71 |
| Integra LifeSciences Holdings (IART) | United States | $2.016B | 10.53 |
| Alphatec Holdings (ATEC) | United States | $1.710B | 0.00 |
| Artivion (AORT) | United States | $1.309B | 86.72 |
| RxSight (RXST) | United States | $1.273B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.214B | 0.00 |
| Paragon 28 (FNA) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.024B | 0.00 |
| AxoGen (AXGN) | United States | $0.806B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.795B | 13.51 |
| IRadimed (IRMD) | United States | $0.759B | 40.99 |
| Mesa Laboratories (MLAB) | United States | $0.743B | 17.51 |
| SiBone (SIBN) | United States | $0.722B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.715B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.649B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.602B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.504B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.500B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.491B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.483B | 25.41 |
| NeuroPace (NPCE) | United States | $0.438B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.429B | 23.23 |
| Pacific Biosciences Of California (PACB) | United States | $0.427B | 0.00 |
| CVRx (CVRX) | United States | $0.409B | 0.00 |
| Inogen (INGN) | United States | $0.298B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.223B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.197B | 0.00 |
| Nevro (NVRO) | United States | $0.190B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.155B | 0.00 |
| LENSAR (LNSR) | United States | $0.129B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 11.75 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.105B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.096B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.085B | 0.00 |
| 908 Devices (MASS) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.076B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.069B | 0.00 |
| InspireMD (NSPR) | Israel | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.059B | 30.86 |
| EnVVeno Medical (NVNO) | United States | $0.055B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.053B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Microbot Medical (MBOT) | United States | $0.036B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Envoy Medical (COCH) | United States | $0.032B | 0.00 |
| NexGel (NXGL) | United States | $0.024B | 0.00 |
| DarioHealth (DRIO) | United States | $0.022B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.005B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.005B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |